University of Texas/MD Anderson

Houston, Texas 77230

6 studies enrolling now · 23 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Advanced Solid Tumors With HER2 Abnormalities, Advanced Solid Tumors With HER3 Abnormalities, Anesthesia, Anesthesia Awareness, Anesthesia Complication, Anesthesia Morbidity, B-Cell Leukemia, B-Cell Lymphoma, CIN 2/3

Studies at this site

• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — Recruiting now
• A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS) — Recruiting now
• Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) — Recruiting now
• Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial — Recruiting now
• A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML) — Completed
• Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes — Completed
• A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities — Stopped early
• Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma — Status unconfirmed
• An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) — Completed
• (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST — Completed
• Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer — Completed
• Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma — Completed
• A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL — Completed
• The Chimerix CMX001 Registry — Stopped early
• Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections — Completed
• A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer — Completed
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma — Stopped early
• A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers — Status unconfirmed
• Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma — Completed
• Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer — Completed